Abstract: The invention provides a novel method of treating respiratory diseases, e.g., pediatric asthma, in a continuing regimen with not more than one daily dose of the drug budesonide using a nebulizer.
Abstract: The present invention relates to compositions and methods for pulmonary administration of full-length parathyroid hormone to mammalian hosts for the treatment of osteoporosis. Thus there is provided a therapeutic preparation comprising a human full-length parathyroid hormone, or homologues thereof, in the form of a dry powder suitable for inhalation in which at least 50% of said dry powder consists of (a) particles having a diameter of up to 10 microns; or (b) agglomerates, of such particles.
Type:
Application
Filed:
August 19, 2002
Publication date:
April 3, 2003
Applicant:
Astra Aktiebolag, a Sweden corporation
Inventors:
Kjell Backstrom, Bjorn Wallmark, Magnus Dahlback, Peter Edman, Ann Johansson